Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Kidney Neoplasms
×
lenvatinib
×
Clear all
Filters
3
NCT05030506
2025-12-18
MK-6482-010
Merck Sharp & Dohme LLC
Phase 1
Active not recruiting
45 enrolled